The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions
Open accessAbstract
Low back pain (LBP) is a major reason for disability, and symptomatic intervertebral disc (IVD) degeneration (IDD) contributes to roughly 40% of all LBP cases.Current treatment modalities for IDD include conservative and surgical strategies.Unfortunately, there is a significant number of patients in which conventional therapies fail with the result that these patients remain suffering from chronic pain and disability.Furthermore, none of the current therapies successfully address the underlying biological problem -the symptomatic degenerated disc.Both spinal fusion as well as total disc replacement devices reduce spinal motion and are associated with adjacent segment disease.Thus, there is an unmet need for novel and stage-adjusted therapies to combat IDD.Several new treatment options aiming to regenerate the IVD are currently under investigation.The most common approaches include tissue engineering, growth factor therapy, gene therapy, and cell-based treatments according to the stage of degeneration.Recently, the regenerative activity of small molecules (low molecular weight organic compounds with less than 900 daltons) on IDD was demonstrated.However, small molecule-based therapy in IDD is still in its infancy due to limited knowledge about the mechanisms that control different cell signaling pathways of IVD homeostasis.Small molecules can act as anti-inflammatory, anti-apoptotic, anti-oxidative, and anabolic agents, which can prevent further degeneration of disc cells and enhance their regeneration.This review pursues to give a comprehensive overview of small molecules, focusing on low molecular weight organic compounds, and their potential utilization in patients with IDD based on recent in vitro, in vivo, and pre-clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, W., Li, P., Xu, J., Wu, X., Guo, Z., Fan, L., Song, R., Wang, J., Li, W., & Teng, H. (2017) · Bioscience Reports · doi:10.1042/bsr20171454 · Cited by 75
RetractedOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Epidemiological features of chronic low-back pain
Andersson, G. B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01312-4 · Cited by 3,181
Hallmarks of Cellular Senescence
Hernandez-Segura, A., Nehme, J., & Demaria, M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.02.001 · Cited by 2,605
Maher, C., Underwood, M., & Buchbinder, R. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30970-9 · Cited by 2,535
How to calculate sample size in animal studies?
Charan, J., & Kantharia, N. D. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.119726 · Cited by 1,881 · cited 1×
“Moreover, if ethical considerations allow for it, a higher number of animals for in vivo studies could be used to decrease the outcome variation and make it easier to draw conclusions [125].”
What is Intervertebral Disc Degeneration, and What Causes It?
Adams, M. A., & Roughley, P. J. (2006) · Spine · doi:10.1097/01.brs.0000231761.73859.2c · Cited by 1,780
Role of cytokines in intervertebral disc degeneration: pain and disc content
Risbud, M. V., & Shapiro, I. M. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.160 · Cited by 1,767
Lumbar Disc Disorders and Low-Back Pain: Socioeconomic Factors and Consequences
Katz, J. N. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.01273 · Cited by 1,645
The economic burden of back pain in the UK
Maniadakis, N., & Gray, A. (2000) · Pain · doi:10.1016/s0304-3959(99)00187-6 · Cited by 1,510
Cited by
From hyperglycemia to intervertebral disc damage: exploring diabetic-induced disc degeneration
Li, S., Du, J., Huang, Y., Gao, S., Zhao, Z., Chang, Z., Zhang, X., & He, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355503 · Cited by 32
Metadata
- Authors
- Kamali, A., Ziadlou, R., Lang, G., Pfannkuche, J., Cui, S., Li, Z., Richards, R. G., Alini, M., & Grad, S.
- Venue
- Theranostics
- Publisher
- Ivyspring International Publisher
- Published
- 2021
- Volume
- 11
- Issue
- 1
- Pages
- 27-47
- ISSN
- 1838-7640 (ISSN-L)
- OpenAlex
- W3092200253
- Cited by
- 263
- References
- 112
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions. https://app.cochat.ai/papers/10.7150/thno.48987
- The paper
- Kamali, A., Ziadlou, R., Lang, G., Pfannkuche, J., Cui, S., Li, Z., Richards, R. G., Alini, M., & Grad, S. (2021). Small molecule-based treatment approaches for intervertebral disc degeneration: Current options and future directions. Theranostics. https://doi.org/10.7150/thno.48987
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.